Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wikström

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|October 1, 1989
Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating propertiesH Wikström, B Andersson, A Svensson, et al.
Journal of Neural Transmission|January 1, 1986
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptorsK Svensson, S Hjorth, D Clark, et al.
Psychopharmacology|December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907H Hall, C Halldin, D Dijkstra, et al.
Journal of Medicinal Chemistry|November 1, 1987
(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonistL E Arvidsson, A M Johansson, U Hacksell, et al.
Journal of Medicinal Chemistry|June 23, 1999
New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluationY Liao, B J Venhuis, N Rodenhuis, et al.
Journal of Medicinal Chemistry|January 1, 1984
8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonistsL E Arvidsson, U Hacksell, A M Johansson, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of lipid peroxidation mediated by indolizinesA I Nasir, L L Gundersen, F Rise, et al.
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
European Journal of Pharmacology|November 16, 1993
Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligandG Damsma, T Bottema, B H Westerink, et al.
Journal of Medicinal Chemistry|October 29, 1993
Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivoC Sonesson, M Boije, K Svensson, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|October 1, 1989
Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating propertiesH Wikström, B Andersson, A Svensson, et al.
Journal of Neural Transmission|January 1, 1986
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptorsK Svensson, S Hjorth, D Clark, et al.
Psychopharmacology|December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907H Hall, C Halldin, D Dijkstra, et al.
Journal of Medicinal Chemistry|November 1, 1987
(+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonistL E Arvidsson, A M Johansson, U Hacksell, et al.
Journal of Medicinal Chemistry|June 23, 1999
New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluationY Liao, B J Venhuis, N Rodenhuis, et al.
Journal of Medicinal Chemistry|January 1, 1984
8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonistsL E Arvidsson, U Hacksell, A M Johansson, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Inhibition of lipid peroxidation mediated by indolizinesA I Nasir, L L Gundersen, F Rise, et al.
Journal of Medicinal Chemistry|February 1, 1985
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonistsH Wikström, B Andersson, D Sanchez, et al.
European Journal of Pharmacology|November 16, 1993
Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligandG Damsma, T Bottema, B H Westerink, et al.
Journal of Medicinal Chemistry|October 29, 1993
Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivoC Sonesson, M Boije, K Svensson, et al.
Pageof 9